Catalent Showcases Advanced Formulations, Development Technologies And Drug Delivery Solutions At CPhI Worldwide
Catalent Pharma Solutions (Booth 3J16), the leading global provider of advanced delivery technologies and development...
Bayer and Forschungszentrum Juelich agree on research collaboration
At the signing ceremony of the new research collaboration: Back row from left: Dr. Simone...
GSK presents positive results from phase III FULFIL study at ERS International Congress
GlaxoSmithKline plc and Innoviva, Inc announced the presentation of further data from the pivotal phase...
Boehringer Ingelheim enters research agreement with Saniona
Boehringer Ingelheim, one of the world’s 20 leading pharmaceutical companies, and Saniona, a leading biotech...
Nymox Pharmaceutical Reports Successful New Long-Term Fexapotide Placebo Crossover Study Results
Nymox Pharmaceutical Corp is pleased to announce successful new study results from the long-term blinded...
Researchers develop safer opioid painkiller from scratch
An international team of researchers - led by scientists at UC San Francisco, Stanford University,...
ViiV Healthcare Begins Phase III Programme To Evaluate Two-drug Regimen For HIV-1 Treatment
ViiV Healthcare announced the start of a phase III programme to support regulatory filings for...
Shortage of estrogen drugs in US worries trans women: ‘It’s my peace of mind’
The two most popular injectables used to transition are disappearing from shelves as one awaits...
Lupin largest drug maker buys 21 generic brands from Shionogi & Co to strengthen...
Lupin Ltd, India’s third largest drug maker, will buy a portfolio of 21 generic brands...
Pfizer adds to list of drugmakers under lens for deviating from good manufacturing practices
Pfizer is the latest addition to an expanding list of drug makers found deviating from...